In this review
The account has a defined job, which is useful
Arc-1’s support page routes prescription questions to Chat with Doctor in the relevant account order. It states a one-business-day response target, identifies account-based refill management and says lab results and clinician notes appear with the related order. Those are specific service features a buyer can evaluate. [1]
They do not establish unlimited visits, an annual test panel or a guaranteed measured response time. I would choose the service around an actual clinical need and confirm who handles that need after the first order. A place to view a lab result is different from an agreement that includes collecting, interpreting and acting on every test.
For a program with stated annual appointments, compare our Ivologist annual-visit membership review.
For a different term-total and staged-cancellation agreement, compare our RxION care-and-refund review.
The product catalogue is not one preventive-care membership
The home page presents NAD+, sermorelin, weight-care medicines and other treatments as separate products. NAD+ injection and sermorelin advertise subscription rates as low as $239.99 monthly; nasal spray advertises $94.99. These are individual purchase conditions, not a single fee covering the entire range. [2] [3] [4] [5]
Tirzepatide has another pricing question: $149 monthly in its product text versus a $199.99 catalogue start. Confirm the chosen preparation, supply and payment before combining services in a budget. The website also displays a construction notice, so check current access and the care pathway rather than assuming every catalogue item can be enrolled in immediately. [2] [6]
Keep individual purchases and recurring charges separate in the health-service full-cost planner.
A longevity label should not decide the clinical outcome
Arc-1 links its treatment approach to proactive aging and offers a biological-age calculator. Neither the category nor a resulting age estimate establishes that a particular prescription extends healthy lifespan. The same applies to energy, cognition and recovery claims: the preparation, population and meaningful outcome still matter. [2] [3] [5]
Compounded products are not FDA-approved, and a product containing the same named ingredient as a branded medicine does not inherit that approval or all of its trial results. Choose a defined clinical service and discuss the actual prescription with its clinician. Ordinary preventive care should not be valued by how many additional treatments or measurements appear in a shopping account. [7]
Keep the measurement distinct from a health outcome in the evidence on biological-age testing.
The general return policy needs a treatment-specific agreement
The site advertises a thirty-day guarantee while its support page says prescriptions are generally not returnable. The general refund policy requires original-condition unused goods, proof of purchase and return approval; it includes exceptions and describes six to eight weeks for an approved refund. Those conditions limit the practical flexibility of the purchase. [1] [2] [8]
Confirm what applies to the actual prescription and recurring order before payment. The described support channel is a useful feature when it meets a defined need, but it does not substitute for a stated visit schedule or preventive-care agreement. Compare a program with explicit annual appointments separately when those appointments are what the reader is missing. [1] [8]
Compare a different prescription and retail arrangement with our BloomMD care-platform review.
Understanding the cost
Treatments are separate purchases. NAD+ injection and sermorelin advertise subscription rates as low as $239.99/month; nasal $94.99/month. Catalogue and product prices differ for tirzepatide. Confirm actual access, selected preparation, supplied term and full payment/renewal agreement.
Build your cost estimateSources
- Arc-1: clinician messaging, refills, lab results and prescription-return restriction
- Arc-1: current catalogue prices, construction notice and consultation invitation
- Arc-1: NAD+ injection offer and subscription condition
- Arc-1: NAD+ nasal spray, bottle volume and subscription wording
- Arc-1: sermorelin subscription offer and clinical access conditions
- Arc-1: compounded tirzepatide formulation and differing price statements
- FDA: compounded drugs are not FDA-approved
- Arc-1: conditional returns, prior authorization and approved-refund timing
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.